113 related articles for article (PubMed ID: 25969367)
41. The incidence of other primary tumours in patients with oral cancer in Scotland.
Crosher R; McIlroy R
Br J Oral Maxillofac Surg; 1998 Feb; 36(1):58-62. PubMed ID: 9578260
[TBL] [Abstract][Full Text] [Related]
42. Atopic diseases, immunoglobulin E and risk of cancer of the prostate, breast, lung and colorectum.
Wang H; Rothenbacher D; Löw M; Stegmaier C; Brenner H; Diepgen TL
Int J Cancer; 2006 Aug; 119(3):695-701. PubMed ID: 16506215
[TBL] [Abstract][Full Text] [Related]
43. Upper aerodigestive tract cancer in patients with chronic lymphocytic leukemia: incidence, stage, and outcome.
Pagedar NA; Halfdanarson TR; Karnell LH; Hoffman HT; Funk GF
Arch Otolaryngol Head Neck Surg; 2012 Dec; 138(12):1171-5. PubMed ID: 23247237
[TBL] [Abstract][Full Text] [Related]
44. Occupational asbestos exposure and risk of oral cavity and pharyngeal cancer in the prospective Netherlands Cohort Study.
Offermans NS; Vermeulen R; Burdorf A; Goldbohm RA; Keszei AP; Peters S; Kauppinen T; Kromhout H; van den Brandt PA
Scand J Work Environ Health; 2014 Jul; 40(4):420-7. PubMed ID: 24810833
[TBL] [Abstract][Full Text] [Related]
45. Lung cancer risk in relation to dietary acrylamide intake.
Hogervorst JG; Schouten LJ; Konings EJ; Goldbohm RA; van den Brandt PA
J Natl Cancer Inst; 2009 May; 101(9):651-62. PubMed ID: 19401552
[TBL] [Abstract][Full Text] [Related]
46. Cancer risk among Danish and Italian farmers.
Ronco G; Costa G; Lynge E
Br J Ind Med; 1992 Apr; 49(4):220-5. PubMed ID: 1571291
[TBL] [Abstract][Full Text] [Related]
47. Body mass index, abnormal glucose metabolism, and mortality from hematopoietic cancer.
Chiu BC; Gapstur SM; Greenland P; Wang R; Dyer A
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2348-54. PubMed ID: 17164355
[TBL] [Abstract][Full Text] [Related]
48. Incidence of leukemia, lymphoma, and multiple myeloma in Czech uranium miners: a case-cohort study.
Rericha V; Kulich M; Rericha R; Shore DL; Sandler DP
Environ Health Perspect; 2006 Jun; 114(6):818-22. PubMed ID: 16759978
[TBL] [Abstract][Full Text] [Related]
49. Increased risk of chronic lymphocytic leukaemia among cancer survivors in the Netherlands: increased detection, causal factors or both?
van den Broek EC; Liu L; Posthuma EF; Janssen-Heijnen ML; Coebergh JW; Soerjomataram I
Ann Hematol; 2014 Jan; 93(1):157-62. PubMed ID: 24381068
[TBL] [Abstract][Full Text] [Related]
50. Coffee consumption and the risk of oral, pharyngeal, and esophageal cancers in Japan: the Miyagi Cohort Study.
Naganuma T; Kuriyama S; Kakizaki M; Sone T; Nakaya N; Ohmori-Matsuda K; Nishino Y; Fukao A; Tsuji I
Am J Epidemiol; 2008 Dec; 168(12):1425-32. PubMed ID: 18974083
[TBL] [Abstract][Full Text] [Related]
51. Risk of cancer among workers exposed to trichloroethylene: analysis of three Nordic cohort studies.
Hansen J; Sallmén M; Seldén AI; Anttila A; Pukkala E; Andersson K; Bryngelsson IL; Raaschou-Nielsen O; Olsen JH; McLaughlin JK
J Natl Cancer Inst; 2013 Jun; 105(12):869-77. PubMed ID: 23723420
[TBL] [Abstract][Full Text] [Related]
52. Epstein-Barr virus DNA load in chronic lymphocytic leukemia is an independent predictor of clinical course and survival.
Visco C; Falisi E; Young KH; Pascarella M; Perbellini O; Carli G; Novella E; Rossi D; Giaretta I; Cavallini C; Scupoli MT; De Rossi A; D'Amore ES; Rassu M; Gaidano G; Pizzolo G; Ambrosetti A; Rodeghiero F
Oncotarget; 2015 Jul; 6(21):18653-63. PubMed ID: 26087198
[TBL] [Abstract][Full Text] [Related]
53. Low IgE monoclonal gammopathy level in serum highlights 20-yr survival in a case of IgE multiple myeloma.
Hayes MJ; Carey JL; Krauss JC; Hedstrom DL; Gulbranson RL; Keren DF
Eur J Haematol; 2007 Apr; 78(4):353-7. PubMed ID: 17378894
[TBL] [Abstract][Full Text] [Related]
54. IgE deficiency and prior diagnosis of malignancy: Results of the 2005-2006 National Health and Nutrition Examination Survey.
Ferastraoaru D; Rosenstreich D
Ann Allergy Asthma Immunol; 2018 Nov; 121(5):613-618. PubMed ID: 30086407
[TBL] [Abstract][Full Text] [Related]
55. B cell neoplasms and occupational asbestos exposure.
Schwartz DA; Vaughan TL; Heyer NJ; Koepsell TD; Lyon JL; Swanson GM; Weiss NS
Am J Ind Med; 1988; 14(6):661-71. PubMed ID: 3232686
[TBL] [Abstract][Full Text] [Related]
56. Follow up of mortality and incidence of cancer 1952-98 in men from the UK who participated in the UK's atmospheric nuclear weapon tests and experimental programmes.
Muirhead CR; Bingham D; Haylock RG; O'Hagan JA; Goodill AA; Berridge GL; English MA; Hunter N; Kendall GM
Occup Environ Med; 2003 Mar; 60(3):165-72. PubMed ID: 12598662
[TBL] [Abstract][Full Text] [Related]
57. B-cell chronic lymphocytic leukemia associated with high serum IGE levels and pruriginous skin lesions: successful therapy with IFN-alpha 2b after failure on IFN-gamma.
Neuber K; Berg-Drewniock B; Volkenandt M; Neumaier M; Zeller W; Gross G; Ring J
Dermatology; 1996; 192(2):110-5. PubMed ID: 8829490
[TBL] [Abstract][Full Text] [Related]
58. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
Hisada M; Chen BE; Jaffe ES; Travis LB
J Natl Cancer Inst; 2007 Feb; 99(3):215-22. PubMed ID: 17284716
[TBL] [Abstract][Full Text] [Related]
59. Use of hair coloring products and the risk of lymphoma, multiple myeloma, and chronic lymphocytic leukemia.
Zahm SH; Weisenburger DD; Babbitt PA; Saal RC; Vaught JB; Blair A
Am J Public Health; 1992 Jul; 82(7):990-7. PubMed ID: 1609918
[TBL] [Abstract][Full Text] [Related]
60. Sunlight and non-Hodgkin's lymphoma: a population-based cohort study in Sweden.
Adami J; Gridley G; Nyrén O; Dosemeci M; Linet M; Glimelius B; Ekbom A; Zahm SH
Int J Cancer; 1999 Mar; 80(5):641-5. PubMed ID: 10048959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
